Introduction
Introduction Statistics Contact Development Disclaimer Help
Development and Evaluation of Polyherbal Formulation for Anti Diabe...
by Biological Sciences
Thumbnail
Download
Web page
ABSTRACT
Diabetes is the most common metabolic disorder that
involves various pathogenic mechanisms and is
characterized by high blood sugar levels. Genetic and
environmental factors cause insufficient insulin
secretion, increased glucose production, abnormal fat, or
protein metabolism. Major sources of diabetes are chronic
complications that started with prolonged hyperglycemia.
According to ayurvedic scriptures such as Charak Samhita,
polyherbal formulations have been mentioned to have anti-
diabetic potentials. Thus, the present study was aimed to
find the anti-diabetic effect of polyherbal formulation
in rat models. Diabetes was induced by a single dose of
Streptozotocin (60 mg/kg) for 72 hours. The effect of the
polyherbal formulation was studied in diabetic rats for
21 days. The biochemical and anti-oxidant parameters such
as fasting blood glucose, cholesterol, triglycerides,
HDL, LDL, VLDL, SGOT, SGPT, Urea, Uric acid, LPO, SOD,
and GSH were measured during the study. The polyherbal
formulation produced a significant reduction of fasting
blood glucose and lipid profile. Kidney function tests,
liver function tests, and anti-oxidant parameters were
also improved. Overall, after 21 days of study, the
results show that the polyherbal formulation is much more
effective for type 1 diabetes in rats.
Date Published: 2022-02-17 21:56:04
Identifier: barti-h-et-al.-2021-2
Item Size: 5473111
Language: eng
Media Type: texts
# Topics
Diabetes
Insulin
Polyherbal formulation
Lipid Profile
Anti-oxidant
# Collections
opensource
community
# Uploaded by
@ir_research_publication
# Similar Items
View similar items
PHAROS
You are viewing proxied material from tilde.pink. The copyright of proxied material belongs to its original authors. Any comments or complaints in relation to proxied material should be directed to the original authors of the content concerned. Please see the disclaimer for more details.